Epigenetic Alterations of the Dopaminergic System in Major Psychiatric Disorders

  • Hamid Mostafavi Abdolmaleky
  • Cassandra L. Smith
  • Jin-Rong Zhou
  • Sam Thiagalingam
Part of the Methods in Molecular Biology™ book series (MIMB, volume 448)


Although there is evidence to link schizophrenia (SCZ) and bipolar disorder (BD) to genetic and environmental factors, specific individual or groups of genes/factors causative of the disease have been elusive to the research community. An understanding of the molecular aberrations that cause these mental illnesses requires comprehensive approaches that examine both genetic and epigenetic factors. Because of the overwhelming evidence for the role of environmental factors in the disease presentation, our initial approach involved deciphering how epigenetic changes resulting from promoter DNA methylation affect gene expression in SCZ and BD. Apparently, the central reversible but covalent epigenetic modification to DNA is derived from methylation of the cytosine residues that is potentially heritable and can affect gene expression and downstream activities. Environmental factors can influence DNA methylation patterns and hence alter gene expression. Such changes can be especially problematic in individuals with genetic susceptibilities to specific diseases. Recent reports from our laboratory provided compelling evidence that both hyper- and hypo-DNA methylation changes of the regulatory regions play critical roles in defining the altered functionality of genes in major psychiatric disorders such as SCZ and BD. In this chapter, we outline the technical details of the methods that could help to expand this line of research to assist with compiling the differential methylation-mediated epigenetic alterations that are responsible for the pathogenesis of SCZ, BD, and other mental diseases. We use the genes of the extended dopaminergic (DAergic) system such as membrane-bound catechol-O-methyltransferase (MB-COMT), monoamine oxidase A (MAOA), dopamine transporter 1 (DAT1), tyrosine hydroxylase (TH), dopamine (DA) receptors1 and 2 (DRD1/2), and related genes (e.g., reelin [RELN] and brain-derived neurotrophic factor [BDNF]) to illustrate the associations between differential promoter DNA methylations and disease phenotype. It is our hope that comprehensive analyses of the DAergic system as the prototype could provide the impetus and molecular basis to uncover early markers for diagnosis, help in the understanding of differences in disease severity in individuals with similar or identical genetic makeup, and assist with the identification of novel targets for therapeutic applications.


Bipolar disorder COMT DNA methylation DRD1 DRD2 epigenetic MAOA RELN QM-MSP schizophrenia 


  1. 1.
    Kravariti, E., Dixon, T., Frith, C., Murray, R., and McGuire, P. (2005) Association of symptoms and executive function in schizophrenia and bipolar disorder. Schizophr. Res. 74, 221–231.CrossRefPubMedGoogle Scholar
  2. 2.
    Sadock, B., and Sadock., V. (2005): Kaplan and Sadock's comprehensive textbook of psychiatry, vol. 1. Philadelphia: Lippincott, Williams & Wilkins; pp. 236–272, 1330–1395.Google Scholar
  3. 3.
    Abdolmaleky, H. M., Thiagalingam, S., and Wilcox, M. (2005) Genetics and epigenetics in major psychiatric disorders: dilemmas, achievements, applications and future scope. Am. J. Pharmacogenomics. 5, 1175–2203.CrossRefGoogle Scholar
  4. 4.
    Pfaff, D. W., Berrettini, W. H., Joh, T. H., and Maxson S. C. (2000) Genetic influences on neural and behavioral functions. New York: CRC Press.Google Scholar
  5. 5.
    Tasman, A., Key, J., and Lieberman, J. (2003) Psychiatry, 2nd ed. West Sussex, UK: Wiley; vol. 1, pp. 254–272.Google Scholar
  6. 6.
    Pyeritz, R. E. (1989) Pleiotropy revisited: molecular explanations of a classic concept. Am. J. Med. Genet. 34, 24–34.Google Scholar
  7. 7.
    Russo, V., Martienssen, R., and Riggs, A. (1996) Epigenetic mechanisms of gene regulation. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.Google Scholar
  8. 8.
    Bird, A. (2002) DNA methylation patterns and epigenetic memory. Genes Dev. 16, 6–21.CrossRefPubMedGoogle Scholar
  9. 9.
    Craddock, N., O'Donovan, M. C., and Owen, M. J. (2005). The genetics of schizophrenia and bipolar disorder: dissecting psychosis. J. Med. Genet. 42, 193–204.CrossRefPubMedGoogle Scholar
  10. 10.
    Petronis, A. (2000) The genes for major psychosis: aberrant sequence or regulation? Neuropsychopharmacology. 23, 1–12.CrossRefPubMedGoogle Scholar
  11. 11.
    Abdolmaleky, H. M., Smith, C.L., Faraone, S.V., et al. (2004) Methylomics in psychiatry: modulation of gene-environment interactions may be through DNA methylation. Am. J. Med. Genet. 127B, 51–59.CrossRefPubMedGoogle Scholar
  12. 12.
    Kandel, E. R. (2001) The molecular biology of memory storage: a dialogue between genes and synapses. Science. 294, 1030–1038.CrossRefPubMedGoogle Scholar
  13. 13.
    Huang, Y. Y., Simpson, E., Kellendonk C., and Kandel E. R. (2004) Genetic evidence for the bidirectional modulation of synaptic plasticity in the prefrontal cortex by D1 receptors. Proc. Natl. Acad. Sci. U. S. A. 101, 3236–3241.CrossRefPubMedGoogle Scholar
  14. 14.
    Martinowich, K., Hattori, D., Wu, H., et al. (2003) DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science. 302, 890–893.CrossRefPubMedGoogle Scholar
  15. 15.
    Chen, W. G., Chang, Q., Lin, Y., et al. (2003) Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science. 302, 885–889.CrossRefPubMedGoogle Scholar
  16. 16.
    Dennis, K. E., and Levitt, P. (2005) Regional expression of brain derived neurotrophic factor (BDNF) is correlated with dynamic patterns of promoter methylation in the developing mouse forebrain. Brain Res. Mol. Brain Res. 140, 1–9.CrossRefPubMedGoogle Scholar
  17. 17.
    Weaver, I. C., Cervoni, N., Champagne, F. A., et al. (2004) Epigenetic programming by maternal behavior. Nat. Neurosci. 8, 847–854.CrossRefGoogle Scholar
  18. 18.
    Murray, R., Granner, D., Mayes, P., and Rodwell, V. (2000) Harper's biochemistry. New York: McGraw-Hill/Appleton & Lange.Google Scholar
  19. 19.
    Thomassin, H., Flavin, M., Espinas, M. L., and Grange, T. (2001) Glucocorticoid-induced DNA demethylation and gene memory during development. EMBO J. 20, 1974–1983.CrossRefPubMedGoogle Scholar
  20. 20.
    Monk, M. (1995) Epigenetic programming of differential gene expression in development and evolution. Dev. Genet. 17, 188–197.CrossRefPubMedGoogle Scholar
  21. 21.
    Kim, G. D., Ni, J., Kelesoglu, N., Roberts, R. J., and Pradhan, S. (2002) Co-operation and communication between the human maintenance and de novo DNA (cytosine-5) methyltrans-ferases. EMBO J. 21, 4183–4195.CrossRefPubMedGoogle Scholar
  22. 22.
    Kress, C., Thomassin, H., and Grange, T (2001) Local DNA demethylation in vertebrates: how could it be performed and targeted? FEBS Lett. 494,135–140.CrossRefPubMedGoogle Scholar
  23. 23.
    Fang, M. Z., Wang, Y., Ai, N., et al. (2003) Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res. 63, 7563–7570.PubMedGoogle Scholar
  24. 24.
    Bonsch, D., Lenz, B., Kornhuber, J., and Bleich, S. (2005) DNA hypermethylation of the alpha synuclein promoter in patients with alcoholism. Neuroreport. 16, 167–170.CrossRefPubMedGoogle Scholar
  25. 25.
    Bonsch, D., Lenz, B., Fiszer, R., Frieling, H., Kornhuber, J., and Bleich, S. (2006) Lowered DNA methyltransferase (DNMT-3b) mRNA expression is associated with genomic DNA hypermethylation in patients with chronic alcoholism. J. Neural Transm. 113, 1299–1304.CrossRefPubMedGoogle Scholar
  26. 26.
    Bleich, S., Lenz, B., Ziegenbein, M., et al. (2006) Epigenetic DNA hypermethylation of the HERP gene promoter induces down-regulation of its mRNA expression in patients with alcohol dependence. Alcohol. Clin. Exp. Res. 30, 587–591.CrossRefPubMedGoogle Scholar
  27. 27.
    Abdolmaleky, H. M., Cheng, K. H., Russo, A., et al. (2005) Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report. Am. J. Med. Genet. B Neuropsychiatr. Genet. 134B, 60–66.CrossRefPubMedGoogle Scholar
  28. 28.
    Abdolmaleky, H. M., Cheng, K. H., Faraone, S. V., et al. (2006) Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Hum. Mol. Genet. 15, 3132–3145.Google Scholar
  29. 29.
    Goldstein, J. M., Goodman, J. M., Seidman, L. J., et al. (1999) Cortical abnormalities in schizophrenia identified by structural magnetic resonance imaging. Arch. Gen. Psychiatry. 56, 537–547.CrossRefPubMedGoogle Scholar
  30. 30.
    Sharafi, M. (2005) Comparison of classical and clozapine treatment on schizophrenia using positive and negative syndrome scale of schizophrenia (PANSS) and SPECT imaging. Int. J. Med. Sci. 2, 79–86.PubMedGoogle Scholar
  31. 31.
    Grayson, D. R., Jia, X., Chen, Y., et al. (2005) Reelin promoter hypermethylation in schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 102, 9341–9346.CrossRefPubMedGoogle Scholar
  32. 32.
    Herman, J. G., Graff, J. R., Myohanen, S., Nelkin, B. D., and Baylin, S. B. (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. U. S. A. 93, 9821–9826.CrossRefPubMedGoogle Scholar
  33. 33.
    Sasaki, M., Kaneuchi, M., Sakuragi, N., and Dahiya, R. (2003) Multiple promoters of catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer. Cancer Res. 63, 3101–3106.PubMedGoogle Scholar
  34. 34.
    Weber, M., Davies, J. J., Wittig, D., et al. (2005) Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat. Genet. 37, 853–862.CrossRefPubMedGoogle Scholar
  35. 35.
    Frommer, M., McDonald, L. E., Millar, D. S., et al. (1992) A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl. Acad. Sci. U. S. A. 89, 1827–1831.CrossRefPubMedGoogle Scholar
  36. 36.
    Derks, S., Lentjes, M. H., Hellebrekers, D. M., de Bruine, A. P., Herman, J. G., and van Engeland, M. (2004) Methylation-specific PCR unraveled. Cell Oncol. 26, 291–299.PubMedGoogle Scholar
  37. 37.
    Galm, O., and Herman, J. G. (2005) Methylation-specific polymerase chain reaction. Methods Mol. Med. 113, 279–291.PubMedGoogle Scholar
  38. 38.
    Lewin, J., Schmitt, A. O., Adorjan, P., Hildmann, T., and Piepenbrock, C. (2004) Quantitative DNA methylation analysis based on four-dye trace data from direct sequencing of PCR amplificates. Bioinformatics. 20, 3005–3012.CrossRefPubMedGoogle Scholar
  39. 39.
    Iwamoto, K., Bundo, M., Yamada, K., et al. (2005) DNA methylation status of SOX10 correlates with its downregulation and oligodendrocyte dysfunction in schizophrenia. J. Neurosci. 25, 5376–5381.CrossRefPubMedGoogle Scholar
  40. 40.
    Singal, R., and Ginder, G. D. (1999) DNA methylation. Blood. 93, 4059–4070.PubMedGoogle Scholar
  41. 41.
    Li, L. C., and Dahiya, R. (2002) MethPrimer: designing primers for methylation PCRs. Bioinformatics. 18, 1427–1431.CrossRefPubMedGoogle Scholar
  42. 42.
    Eckhardt, F., Lewin, J., Cortese, R., et al. (2006) DNA methylation profiling of human chromosomes 6, 20 and 22. Nat. Genet. 38, 1378–1385.CrossRefPubMedGoogle Scholar
  43. 43.
    Trinh, B. N., Long, T. I., and Laird, P. W. (2001) DNA methylation analysis by MethyLight technology. Methods. 25, 456–462.CrossRefPubMedGoogle Scholar
  44. 44.
    Chan, M. W., Chu, E. S., To, K. F., and Leung, W. K. (2004) Quantitative detection of methylated SOCS-1, a tumor suppressor gene, by a modified protocol of quantitative real time methylation-specific PCR using SYBR green and its use in early gastric cancer detection. Biotechnol. Lett. 26, 1289–1293.CrossRefPubMedGoogle Scholar
  45. 45.
    Fackler, M. J., McVeigh, M., Mehrotra, J., et al. (2004) Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer. Cancer Res. 64, 4442–4452.CrossRefPubMedGoogle Scholar
  46. 46.
    Swift-Scanlan, T., Blackford, A., Argani, P., Sukumar, S., and Fackler, M. J. (2006) Two-color quantitative multiplex methylation-specific PCR. Biotechniques. 40, 210–219.CrossRefPubMedGoogle Scholar

Copyright information

© Humana Press, a part of Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Hamid Mostafavi Abdolmaleky
    • 1
  • Cassandra L. Smith
    • 2
  • Jin-Rong Zhou
    • 3
  • Sam Thiagalingam
    • 4
  1. 1.Laboratory of Nutrition and Metabolism at BIDMC, Harvard Medical School, and Biomedical Engineering DepartmentBoston UniversityBostonMassachusetts
  2. 2.Molecular Biotechnology Research Laboratory, Biomedical Engineering Department, College of EngineeringBoston UniversityBostonMassachusetts
  3. 3.Laboratory of Nutrition and Metabolism at BIDMC, Department of SurgeryHarvard Medical SchoolBostonMassachusetts
  4. 4.Departments of Medicine (Genetics Program), Genetics and Genomics, and Pathology and Laboratory MedicineBoston University School of MedicineBostonMassachusetts

Personalised recommendations